Logo image of VSEE

VSEE HEALTH INC (VSEE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VSEE - US92919Y1029 - Common Stock

0.5446 USD
0 (-0.29%)
Last: 12/10/2025, 7:57:12 PM
0.5446 USD
0 (0%)
After Hours: 12/10/2025, 7:57:12 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VSEE. VSEE was compared to 35 industry peers in the Health Care Technology industry. VSEE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, VSEE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VSEE has reported negative net income.
VSEE had a negative operating cash flow in the past year.
In the past 5 years VSEE always reported negative net income.
VSEE had a negative operating cash flow in each of the past 5 years.
VSEE Yearly Net Income VS EBIT VS OCF VS FCFVSEE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -66.71%, VSEE is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -66.71%
ROE N/A
ROIC N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSEE Yearly ROA, ROE, ROICVSEE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100K 200K 300K

1.3 Margins

The Gross Margin of VSEE (54.64%) is worse than 60.00% of its industry peers.
The Profit Margin and Operating Margin are not available for VSEE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSEE Yearly Profit, Operating, Gross MarginsVSEE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

VSEE does not have a ROIC to compare to the WACC, probably because it is not profitable.
VSEE has more shares outstanding than it did 1 year ago.
VSEE has a better debt/assets ratio than last year.
VSEE Yearly Shares OutstandingVSEE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
VSEE Yearly Total Debt VS Total AssetsVSEE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

VSEE has an Altman-Z score of -7.28. This is a bad value and indicates that VSEE is not financially healthy and even has some risk of bankruptcy.
VSEE has a worse Altman-Z score (-7.28) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.28
ROIC/WACCN/A
WACC8.75%
VSEE Yearly LT Debt VS Equity VS FCFVSEE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.16 indicates that VSEE may have some problems paying its short term obligations.
VSEE has a worse Current ratio (0.16) than 97.14% of its industry peers.
VSEE has a Quick Ratio of 0.16. This is a bad value and indicates that VSEE is not financially healthy enough and could expect problems in meeting its short term obligations.
VSEE's Quick ratio of 0.16 is on the low side compared to the rest of the industry. VSEE is outperformed by 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
VSEE Yearly Current Assets VS Current LiabilitesVSEE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

VSEE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.57%, which is quite impressive.
The Revenue has grown by 121.76% in the past year. This is a very strong growth!
EPS 1Y (TTM)77.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.49%
Revenue 1Y (TTM)121.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.67%

3.2 Future

VSEE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -182.84% yearly.
Based on estimates for the next years, VSEE will show a very strong growth in Revenue. The Revenue will grow by 46.40% on average per year.
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VSEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VSEE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSEE Price Earnings VS Forward Price EarningsVSEE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSEE Per share dataVSEE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5

4.3 Compensation for Growth

VSEE's earnings are expected to decrease with -182.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-182.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VSEE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VSEE HEALTH INC

NASDAQ:VSEE (12/10/2025, 7:57:12 PM)

After market: 0.5446 0 (0%)

0.5446

0 (-0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners4.22%
Inst Owner Change257.99%
Ins Owners20.16%
Ins Owner Change0%
Market Cap17.07M
Revenue(TTM)14.55M
Net Income(TTM)-12.48M
Analysts82.86
Price Target5.1 (836.47%)
Short Float %4.71%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.1%
Min Revenue beat(2)-18.49%
Max Revenue beat(2)-7.7%
Revenue beat(4)1
Avg Revenue beat(4)-8.99%
Min Revenue beat(4)-18.49%
Max Revenue beat(4)7.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.46
BVpS-0.18
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.64%
FCFM N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.07%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -7.28
F-Score3
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.49%
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)121.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.67%
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-159.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-244.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-242.52%
OCF growth 3YN/A
OCF growth 5YN/A

VSEE HEALTH INC / VSEE FAQ

What is the ChartMill fundamental rating of VSEE HEALTH INC (VSEE) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VSEE.


What is the valuation status for VSEE stock?

ChartMill assigns a valuation rating of 0 / 10 to VSEE HEALTH INC (VSEE). This can be considered as Overvalued.


How profitable is VSEE HEALTH INC (VSEE) stock?

VSEE HEALTH INC (VSEE) has a profitability rating of 0 / 10.


What is the financial health of VSEE HEALTH INC (VSEE) stock?

The financial health rating of VSEE HEALTH INC (VSEE) is 0 / 10.